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Abstract
Impulsivity is a primary feature of many psychiatric disorders, most notably attention deficit hyperactivity disorder and drug
addiction. Impulsivity includes a number of processes such as the inability to delay gratification, the inability to withhold a
motor response, or acting before all of the relevant information is available. These processes are mediated by neural
systems that include dopamine, serotonin, norepinephrine, glutamate and cannabinoids. We examine, for the first time, the
role of opioid systems in impulsivity by testing whether inactivation of the mu- (Oprm1) or delta- (Oprd1) opioid receptor
gene alters motor impulsivity in mice. Wild-type and knockout mice were examined on either a pure C57BL6/J (BL6) or a
hybrid 50% C57Bl/6J–50% 129Sv/pas (HYB) background. Mice were trained to respond for sucrose in a signaled nose poke
task that provides independent measures of associative learning (responses to the reward-paired cue) and motor
impulsivity (premature responses). Oprm1 knockout mice displayed a remarkable decrease in motor impulsivity. This was
observed on the two genetic backgrounds and did not result from impaired associative learning, as responses to the cue
signaling reward did not differ across genotypes. Furthermore, mutant mice were insensitive to the effects of ethanol, which
increased disinhibition and decreased conditioned responding in wild-type mice. In sharp contrast, mice lacking the Oprd1
gene were more impulsive than controls. Again, mutant animals showed no deficit in associative learning. Ethanol
completely disrupted performance in these animals. Together, our results suggest that mu-opioid receptors enhance,
whereas delta-opioid receptors inhibit, motor impulsivity. This reveals an unanticipated contribution of endogenous opioid
receptor activity to disinhibition. In a broader context, these data suggest that alterations in mu- or delta-opioid receptor
function may contribute to impulse control disorders.
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Introduction
Impulsivity is a behavioral trait that varies across the general
population. Extreme manifestations of impulsivity are revealed in
a variety of pathological conditions including antisocial and
borderline personality disorders, attention deficit hyperactivity
disorder (ADHD), pathological gambling, eating disorders,
obsessive-compulsive disorder and substance abuse [1]. Patients
with neurological impairments such as Parkinson’s disease,
Schizophrenia, Tourette’s syndrome and frontal lobe dementia
also present with clinical features of impulsivity. The pervasiveness
of this trait across patient populations, and the fact that it is a
significant predictor of therapeutic efficacy for some disorders [2–
4], provide compelling arguments for understanding the neuro-
pharmacology of impulsivity.
Altered serotoninergic transmission has long been associated
with impulse control disorders [5], and an important role for
dopamine (DA) has been inferred from the therapeutic efficacy of
psychostimulants in the treatment of ADHD [6]. Moreover, in
humans, polymorphisms in serotonin (5-HT) and DA transporters
or receptors is associated with ADHD and addiction [7]. Animal
research has confirmed an important role for both DA and 5-HT
in impulsivity, and also implicated norepinephrine, glutamate, and
cannabinoid systems [8]. To date, no one has investigated the role
of opioid systems in impulsivity using animal models.
Opioid receptors have been studied extensively in relationship
to drug abuse. The opioid system consists of endogenous
neuropeptides that produce effects by acting at mu, delta and
kappa opioid receptors. Deletion of the mu-opioid receptor gene
(Oprm1
2/2) in mice reduces or eliminates the rewarding properties
of opioids as well as non-opioid drugs such as ethanol, cocaine,
nicotine and cannabinoids. The consistency of behavioral effects
across different classes of abused drugs led to the hypothesis that
mu-opioid receptors represent a gateway to drug addiction [9].
Unlike mu-opioid receptor knockout mutants, mice lacking the
delta opioid receptor gene (Oprd1
2/2) show intact cannabinoid-
induced reward [10] and increased self-administration of ethanol
[11]. These mice exhibit increased depressive-like behaviors and
higher basal anxiety levels [12], the latter of which is reversed
following ethanol intake [11]. Delta opioid receptors, therefore,
influence emotional responses and this, in turn, impacts on drug
taking behaviors.
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adaptations of the brain to repeated drug exposure. The rewarding
properties of drugs promote initial drug use when drugs are
consumed voluntarily but, as the disorder develops, addicts lose
control of their behavior and drug intake becomes independent of
drug reward [13,14]. Impulsivity is a critical feature of this state in
that addicts are unable to inhibit their drug-taking responses even
if the subsequent rewarding effects of the drug are minimal. The
question then arises, whether mu- and delta-opioid receptors, in
addition to their roles in reward and emotional processing, also
regulate impulsivity. Mu and delta knockout animals exhibit marked
opposing phenotypes in a number of tasks (locomotor activity, dark-
light box, elevated plus maze, forced swim); in contrast, kappa
receptor knockout mice are comparable to wild-type controls in
these tests [12]. Thus, as a first step in studying the role of opioid
receptors to motor impulsivity, we elected to examine mu and delta
mutant lines. To thisaim,we tested whetherdeletion of the Oprm1 or
the Oprd1 gene alters motor impulsivity in mice. We used a signaled
nose poke task [15] that provides independent measures of
impulsivity (the inability to withhold a prepotent response) and
conditioned reward (approach responses to a light previously paired
with a sucrose reward). Micearerequiredtowithhold responding for
a liquid sucrose reward until a visual cue is presented (Fig. 1).
Impulsivity inthis task is comparable to premature responding inthe
5-choice serial reaction time task or disinhibition in the go/no-go
task, two standard measures of impulsivity in rodents. Compared to
these other tests, however, the signaled nose poke task is acquired
rapidly and optimal performance does not rely as heavily on
attentional (5-choice) or discriminative (go/no-go) abilities. Impor-
tantly, performance in the signaled nose poke task seldom reaches
asymptotic levels, allowing both increases and decreases in
impulsivity to be easily detected. Given the role of endogeneous
opioids in the neuropharmacological effects of ethanol [16], and the
common assumption that ethanol intoxication is associated with
impulsive behavior in humans [17], we performed one additional
test in which we evaluated whether ethanol alters performance of
wild-type or knockout mice in the signaled nose poke task.
Materials and Methods
Subjects
Mu- and delta-opioid receptor knockout mice and their wild-
type controls were bred in-house and genotyped a few days after
birth. Mice were bred on either a hybrid 50% 129SVPas 50%
C57Bl6J background (HYB), (the original background of opioid
receptor knockout mice) or backcrossed onto the C57Bl6J
background (classically used in mouse behavioral studies) for
more than 12 generations (BL6). A detailed description of the
construction of these lines and their genotyping has been described
previously [12,18].
At 112–126 days of age, mice were transferred from the breeding
facility to the phenotyping centre where they were group housed on
a 12-h light/dark cycle with lights on at 700 am. Food was available
ad libitum throughout the experiment; with the exceptions noted
below; access to water was restricted to 2 h per day beginning 2–4 h
after testing. Behavioral testing commenced at 17–20 weeks of age
and finished at 26–33 weeks of age. All animals were weighed twice
perweek;therewerenosignificantgroup differencesinweight across
the experiment. Animal care was conducted in accordance with the
European Communities Council Directive of 24 November 1986
(86/609/EEC) and the experiments were approved by the Comite ´
re ´gional d’e ´thique en matie `re d’experimentation animale de
Strasbourg, CREMEAS, 2003-10-08-[1]-58.
Apparatus
Impulsivity testing was conducted in operant boxes
(26.5622.0620.0 cm) housed in a sound-attenuating chamber
(Coulbourn Instruments, Allentown PA). Each box was fitted with
two nose poke response holes, a cue light, a houselight and a liquid
dipper that was accessed through a recessed magazine. Sucrose
delivery was signaled by an infrared light located 4 cm above the
magazine. Nose pokes and entries to the magazine were detected
by infrared beams crossing each opening vertically. The control of
stimuli and recording of responses were managed by an IBM-type
computer using Graphic State Notation 2 software.
Sucrose and water consumption were measured in 24
automated chambers (11622619 cm) made of wire mesh floor
and Plexiglas sidewalls (Imetronic, Pessac, France). Each cage was
fitted with infra-red captors located 2 and 8.5 cm from the floor,
allowing measurement of ambulatory locomotor activity and rears,
respectively. Water and sucrose consumption were measured using
an automated lickometer.
Behavioral procedures
Signaled nose poke task. Mice were trained in the signaled
nose poke task as described previously [15] with minor
modifications. These included the cue signaling reward
availability (5 s visual stimulus rather than a 3 s auditory
stimulus) and the reward (5 s presentation of liquid sucrose
rather than the delivery of a single sucrose pellet). The sessions
were increased from 30 to 40 min to accommodate these changes.
Figure 1. The progression of each trial during phase 4 of the signaled nose poke task. Each trial started with a 20 s ITI; responses during
this period had no consequence. Nose pokes during the subsequent pre-CS period (VT 1–8 s) reinstituted the ITI. If mice refrained from responding
during the pre-CS period the trial progressed to the 5 s cue presentation. Nose pokes in the pre-assigned reinforcement hole during the cue
presentation turned off the cue and immediately elevated the sucrose dipper. Nose pokes in the non-reinforced hole had no consequence.
CS=conditioned stimulus; ITI=inter-trial interval; VT=variable time.
doi:10.1371/journal.pone.0004410.g001
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water deprivation, a sucrose solution (25% w/v) was presented in
the home cage for one hour. Beginning the next day, all mice
underwent magazine training (2 sessions) consisting of 30
presentations of liquid sucrose, presented at random intervals
approximately every 30 seconds. During sucrose presentation, the
houselight was turned off and the magazine light was turned on.
Magazine entries were recorded and used as an indicator that
mice had learned the location of the sucrose reward. The liquid
dipper remained elevated for 5 s after a magazine entry to a
maximum of 20 s per sucrose presentation.
Subsequent training was conducted in 4 phases with one
training session per day. In Phase 1, mice were reinforced for nose
poking on a fixed-ratio (FR1) schedule of reinforcement on either
the right or left side (assignment of reinforced hole counterbal-
anced across groups). The discriminative stimulus (i.e., the visual
cue) was turned on throughout these sessions, except during
presentation of the reinforcer (5–20 s elevation of the sucrose
dipper). Training continued until 25 reinforcers were presented in
one session. In Phase 2, response requirements were increased to
an FR3 schedule and the elevation of the sucrose dipper was
limited to 5 s. Training continued until 25 reinforcers were
presented in one session. In Phase 3, the discriminative stimulus
was reduced to 5 s and presented 50 times with a fixed inter-trial-
interval (ITI) of 30 s; only those responses occurring on the
reinforced side during the cue were reinforced (FR1) by a 5 s
elevation of the sucrose dipper. Training progressed to Phase 4
when animals made 10 reinforced nose pokes (i.e., during the cue)
in one session. Animals that did not reach the training criterion in
Phases 1, 2, or 3 after 20 sessions were removed from the
experiment, and data from these sessions was not included in the
statistical analyses. In Phase 4, the ITI was set at 20 s, followed by
a pre-cue interval of 1–8 s. Phase 4 testing continued for 10
sessions. Nose pokes in the presence of the discriminative stimulus
immediately turned off the visual cue and elevated the sucrose
dipper (5 s). In one final session, the duration of the cue
presentation was increased to a maximum of 30 s per trial. Thus,
mice had up to 30 s to detect and respond to the visual cue before
the next ITI was initiated.
Ethanol administration. Following the completion of Phase 4
testing,micewereretestedinthesignalednosepoketaskfollowingan
injection of ethanol (0, 0.75, 1.25, 1.75 g/kg i.p.; 20% w/v in
isotonic saline). Doses were administered in ascending or descending
order (counterbalanced within groups) and all animals were tested
twice at each dose. A minimum of 48 h separated each test.
Sucrose Preference. At the end of all behavioral tests,
sucrose and water intake were assessed for 24 h, beginning at
11:00 during the light cycle (lights off at 19:00). Water and sucrose
(25%) were provided in two bottles at the front of the cage and the
number of licks was automatically scored for each bottle and
measured as a function of time. Regular chow was freely available
throughout the session. Sucrose preference was calculated for each
phase as a percentage of total fluid intake (sucrose and water
combined). Locomotor activity was measured as horizontal beam
breaks at the front and back of the cage.
Statistical analyses
The same wild-type mice on a BL6 background were used the
control group for both mu and delta opioid receptor knockout
mice; separate groups of HYB wild-type animals were used as
controls of Oprm1
2/2 and Oprd1
2/2 groups on a HYB back-
ground. Data were then analyzed separately (Oprm1
2/2 and
Oprd1
2/2) using an analysis of variance (ANOVA) with genotype
(wild-type versus knockout) and background (BL6 versus HYB) as
a between-subjects factors and session as a within-subjects factor
(Magazine training in Phase 4, and Ethanol testing sessions). Post-
hoc analyses were conducted using Tukey’s test. Whenever there
were violations of sphericity, P-values from the Greenhouse-
Geisser correction to the within-group degrees of freedom were
reported for all ANOVA tests. During Magazine training, the total
number of magazine entries, magazine entries during sucrose
presentation and the % of total magazine entries that occurred
during sucrose presentations were analyzed. The dependent
variable in Phases 1–3 was days to criterion. In Phase 4 and
during Ethanol testing, the conditioned responses (CR; reinforc-
ers/cue presentations) and efficiency ratio (reinforcers/nose pokes)
were dependent variables. Appetitive learning is reflected in the
CR measure whereas impulsivity is reflected in the efficiency ratio.
Data from the ethanol sessions were analyzed with genotype and
background as between-subjects factors and dose as a repeated
factor. There was no effect of repeated testing on efficiency ratios
or CR so data were collapsed across this factor. In all sessions, the
number of responses on the non-reinforced side, the number of
magazine entries during reward and non-reward periods, the
latency to enter the magazine following elevation of the sucrose
dipper, were recorded. Sucrose preference data were analyzed
using a two-way ANOVA (genotype x background).
Results
Training
Mice from the six groups progressed through the training phases
of the signaled nose poke task at the same rate (Table 1). All
animals learned the significance of the reward presentation,
evidenced by an increase in the proportion of magazine entries
that occurred during sucrose availability: there were no genotype
or background differences on this measure. Nor were there any
genotype, background or interaction effects on the days to
criterion measure in Phases 1–3 (all Fs,1.2; NS), indicating that
deletion of neither mu-opioid nor delta-opioid receptors affected
learning on this task.
Testing
Deletion of the mu opioid receptor gene decreases motor
impulsivity. Fig. 2 shows the effect of mu-opioid receptor
deletion on testing in the signaled nose poke task. In contrast to the
training data, Oprm1
2/2 mice on both genetic backgrounds per-
formed significantly better than wild-type controls during Phase 4
testing. Efficiency ratios (rewards/nose pokes) increased across 10
sessions [F(9,351)=59.82, p,.01] verifying that all groups were
capable of learning the task (Fig. 2A and 2E). The significant 3-
way interaction [F(9,351)=2.05, p,.05] indicated that the
difference in efficiency ratios between wild-type and knockout
mice depended on the session and the background strain. Pairwise
comparisons revealed that HYB, but not BL6, knockout animals
differed from their wild-type controls on session 6. In sessions 7–
10, BL6 knockout mice performed better than controls, whereas
HYB knockout mice showed higher efficiency ratios only on
session 8. The significant genotype [F(1,39)=8.79, p,.01] and
background [F(1,39)=6.73, p=.05] differences were due to
higher efficiency ratios in both Oprm1
2/2 groups compared to
their own wild-type control, as well as higher efficiency ratios in
the HYB background.
As seen in Fig. 2B and 2F, responses on the rewarded side
during the pre-CS period (variable time 1–8 s) showed a general
decline across sessions, [F(9,351)=19.49, p,.01] and an interac-
tion of this measure with genotype [F(9,351)=5.75, p,.01]. There
were significant genotype [F(1,39)=15.3, p,.01] and background
Opioids and Impulsivity
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responding in the Oprm1
2/2 groups and in the HYB strain.
Responses on the rewarded side during the 20-s inter-trial
interval (ITI) showed a similar pattern [F(9,351)=17.11, p,.01],
but the rate of decrease differed across groups [F(9,351)=2.77,
p,.05] (Fig. 2C and 2G). Responding was similar in all four
groups during the initial sessions, but declined to a lower level in
the Oprm1
2/2 groups by the end of the sessions. The significant
main effects of genotype [F(1,39)=8.2, p,.01] and background
[F(1,39)=4.81, p,.05] reflected lower overall responses in the
Oprm1
2/2 groups and in the HYB strain.
Finally, conditioned responding (rewards/signals) increased
across sessions [F(9,351)=119.51, p,.01], but there were no
genotype or background differences on this measure and no
statistically significant interactions (Fig. 2D and 2H).
Deletion of the delta opioid receptor gene increases motor
impulsivity. Fig. 3 shows the effect of delta opioid receptor
deletion on testing in the signaled nose poke task. Similar to the mu-
opioid receptor knockout animals, efficiency ratios increased across
the 10 testing sessions of Phase 4 [F(9,315)=26.76, p,.01],
indicating that all groups were capable of learning the task (Fig. 3A
and 3E).Thegenotypex session interaction [F(9,315)=3.78, p,.01]
and the main effect of genotype [F(1,35)=11.55, p,.01] were the
result of both Oprd1
2/2 groups achieving lower efficiency ratios (i.e.,
increased impulsivity) compared to their respective control groups
(post-hoc tests p,0.05). In addition, as in the Oprm1
2/2 experiment,
there was a significant difference in the efficiency ratios of the two
wild-type strains, with the HYB animals exhibiting significantly
higher efficiency ratios in sessions 3–10. The session x background
and session x background x genotype interactions were not
statistically significant.
Both the genotype [F(1,35)=4.32, p,.05] and background
[F(1,35)=87.34, p,.01] differences in responding were apparent
during the 1–8 s pre-CS period when animals must learn to inhibit
their responses (Fig. 3B and 3F). Pre-CS responses declined across
sessions [F(9,315)=14.4, p,.01] and the effect was more
pronounced in BL6 mice of both genotypes [F(9,315)=6.3,
p,.01]. Responses also decreased during the ITI period
[F(9,315)=20.24, p,.01] but this factor did not interact with
group or genotype (Fig. 3C and 3G). Unlike pre-CS responses,
there were no group differences in responding during the ITI
period [F(1,35)=3.15, p..05], although the HYB animals
continued to respond at higher rates during this period
[F(1,35)=61.45, p,.01]. Thus, increased responding in the
signaled nose poke task by Oprd1
2/2 mice was confined to the
pre-CS period indicating that these mice are incapable of
refraining from making an anticipated response.
The proportion of CRs also increased across sessions [F(9,315)=
123.29, p,.01] (Fig. 3D and 3H), but there were no significant
genotype or background differences on this measure and none of the
interactions were statistically significant. Thus, in contrast to the
impulsivity measure, the ability to learn a conditioned responses was
not disrupted by deletion of the Oprd1 gene.
In sum, mice lacking mu-opioid receptors were significantly
better at inhibiting a motor response, whereas mice lacking the
delta-opioid receptor were significantly worse.
It is unlikely that these changes in efficiency ratios simply reflect
a general reduction in responding because there were no genotypic
differences in: 1) responses on the non-reinforced side throughout
training and testing (Table 2, left columns) or 2) responses on the
reinforced side during the final sessions of Phases 1–3 or the first
session of Phase 4 (Table 2, right columns). In addition, con-
ditioned responses to the reward-paired cue were similar across
genotype and strain suggesting that differences in associative
learning did not impact on task performance. To evaluate possible
differences in attentional processes, we increased the duration of
the visual cue from 5 to 30 s during a final test session. This
manipulation did not affect efficiency ratios or conditioned
responses in any group (data not shown). The mean latency to
respond to the visual cue in this final session was 2.28 s and less
than 2% of the cue presentations reached the maximum 30 s
duration; there were no genotype or background differences on
either measure. Thus, it is unlikely that the decreased impulsivity
in Oprm1
2/2 mice or the increased impulsivity in Oprd1
2/2 mice
reflects alterations in attentional processes. Finally, sucrose
preference was similar in wild-type and knockout mice, and there
were no strain differences in this measure, ruling out the possibility
that differential responses to the reward influenced our findings
(mean sucrose preference across groups=94.7%).
Ethanol administration alters performance in delta but
not mu opioid receptor knockout mice. Ethanol administra-
tion decreased efficiency ratios and conditioned responses in wild-
type mice but had no effect on mice lacking mu-opioid receptors
(Fig. 4).
As see in Fig. 4A, the effect of ethanol on efficiency ratios was
dependent on dose [F(3,246)=5.95, p,.01] and genotype
Table 1. Training on the signaled nose poke task.
Group Magazine Training Phase 1: FR1 Phase 2: FR3 Phase 3: ITI
Proportion Reward Days to Criterion
wild-type HYB .386.06 .546.04 3.56.35 3.206.31 5.706.41
Oprm1
2/2 HYB .446.05 .516.04 4.06.49 2.706.47 5.206.67
Oprd1
2/2 HYB .426.10 .466.04 2.886.64 3.876.64 6.126.58
wild-type BL6 .416.07 .596.06 4.06.57 3.176.70 6.256.52
Oprm1
2/2 BL6 .486.03 .546.05 4.46.60 3.806.39 5.506.62
Oprd1
2/2 BL6 .536.03 .596.09 3.336.41 4.006.67 6.006.73
The first two columns display the proportion (6SEM) of magazine entries that occurred during elevation of the sucrose dipper across two sessions of magazine training.
The last three columns display the days to criterion measure for Phases 1–3 during task training. With fixed ratio (FR) responding in Phases 1 and 2, the criterion to
progress to the next phase was 25 reinforcers earned per 40-min session. With the introduction of the inter-trial interval (ITI) in Phase 3, this was reduced to 10
reinforcers per session. There were no significance differences between knockout and wild-type animals on any measure.
wild-type HYB, n=20; Oprm1
2/2 HYB, n=10; Oprd1
2/2 HYB, n=8;
wild-type BL6, n=24;Oprm1
2/2 BL6, n=11;Oprd1
2/2 BL6, n=10
doi:10.1371/journal.pone.0004410.t001
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[F(1,82)=13.61, p,.01. Post-hoc tests indicated that these effects
were due to higher efficiency ratios in Oprm1
2/2 animals and an
ethanol-induced decrease in efficiency ratios only in Oprm1
+/+
mice. An analysis of pre-CS responses (Fig. 4B) revealed a
significant effect of dose [F(3,246)=28.6, p,.01], genotype
[F(1,82)=48.3, p,.01] and a dose x genotype interaction
[F(3,246)=17.58, p,.01]. There were no significant strain
differences on any behavioral measure during ethanol testing. A
similar effect was observed during the ITI (Fig. 4C): ethanol
altered responding [F(3,246)=14.06, p,.01] and this effect
interacted with genotype [F(3,246)=13.98, p,.01]. The main
effect of genotype [F(1,82)=104.95, p,.01] confirmed that
Oprm1
2/2 animals were responding at lower rates across doses.
Ethanol also had differential effects on conditioned responses in
Oprm1
2/2 and Oprm1
+/+ mice (Fig. 4D). This was confirmed by
significant main effects of dose [F(3,246)=37.58, p,.01] and
genotype [F(1,82)=8.95, p,.05] and an interaction between the
two [F(1,82)=33.85, p,.01].
Ethanol administration had markedly different effects in
Oprd1
2/2 than in Oprm1
2/2 mice (Fig. 5). Specifically, ethanol
decreased efficiency ratios in both wild-type and knockout mice
[F(3,222)=16.11, p,.01], although the increased impulsivity in
Oprd1
2/2 mice was maintained throughout these sessions
[F(1,74)=32.45, p,.01] (Fig. 5A). Ethanol also produced similar
effects in wild-type and knockout mice as well as the number of
responses that occurred during the pre-CS periods (Fig. 5B)
[F(3,222)=58.71, p,.01], the ITI (Fig. 5C)[F(3,222)=21.37,
p,.01] and as well as on conditioned responses (Fig. 5D)
[F(3,222)=89.95, p,.01]. BL6 animals of both genotypes
exhibited higher rates of responding during the ITI period
[F(1,74)=6.76, p,.05] but none of the other main effects or
interactions were statistically significant.
Discussion
This study demonstrates that mice lacking mu-opioid receptors
exhibit decreased motor impulsivity whereas those lacking delta-
opioid receptors show increased motor impulsivity. Thus, our
results reveal an unforeseen role of endogenous opioid receptor
activity in disinhibition and suggest that mu opioid receptors
promote, whereas delta opioid receptors inhibit, impulsive
behaviors. Future studies, using a similar approach, will determine
whether kappa receptor activity also influences motor impulsivity.
The increased ability to withhold a motor response in Oprm1
2/2
mice occurred when reward-related learning remained intact. The
latterobservationseemstocontrastotherreportsofrewardreduction
in these animals [9]. These studies, however, examined the effect of
mu-opioid receptor gene deletion on the hedonic properties of
abused drugs whereas our study tested nosepoking responses to a
food reward which is not altered in mu-opioid receptor knockout
mice [19]. Importantly, the fact that mu-receptors modulate motor
impulsivity independently from conditioned reward in the signaled
nose poke tasks is consistent with the notion that reward and
impulsivity are mediated by different neural systems [13]. Changes
indrug reward andimpulsivity,therefore,areseparate processesthat
interact to influence the development of addiction: combined with
previous evidence, our findings highlight the fact that mu-opioid
receptors play a key role in both processes. These receptors,
therefore, not only mediate initial drug reward but may also be
implicated in further behavioral changes, such as loss of control, that
occur in chronic drug abusers.
Our findings that mice lacking mu-opioid receptors are less
impulsive has direct relevance to heroin addiction. At least a small
population of heroin addicts exhibit greater binding potential of
mu-opioid receptors [20], suggesting that these individuals should
display the opposite behavior to that of our knockout mice (i.e.,
increased impulsivity). The evidence for this hypothesis is mixed:
although heroin addicts show clear deficits in cognitive or choice
impulsivity [21–23], their performance on tests that measure
motor impulsivity is less clear. Some of these discrepancies may
reflect drug history as pure heroin abusers [24,25], but not heroin
addicts who also abuse other substances [23], exhibit these deficits.
Motor deficits in opiate abusers may also depend on current drug
use because heroin addicts maintained on methadone show motor
impulsivity deficits that are not apparent in abstinent abusers [26].
Although the relationship between the behavior of Oprm1
2/2 mice
and heroin addicts is not straightforward, our results fit well with
evidence that opioid antagonists enhance control of motor
responses in healthy participants [27] and may be effective
treatment in impulse-control disorders [28].
The decreased ability of Oprd1
2/2 mice to withhold a motor
response is intriguing for two reasons. First, these data add to
increasing evidence that mu and delta opioids receptors have
opposing roles in many behavioral responses. These include
anxiety and depressive-like behaviors [12], ethanol self-adminis-
tration [29] and a conditioned place preference to cannabinoids
[10]. The two receptors also differentially regulate mesolimbic DA
tone [30]. Second, clinical research and practice have probed the
function of mu opioid receptors using morphine-derived com-
pounds for decades. In contrast, delta opioid receptor pharma-
cology is less well developed and many aspects of delta receptor
function remain unexplored. Our findings suggest that, in addition
to their anxiolytic and antidepressant effects, delta receptor
agonists are of potential interest for impulse control disorders.
With regards to drug abuse, delta opioid receptors may minimize
changes in emotional state and impulsivity, both of which develop
under chronic drug abuse and contribute to relapse.
Consistent with previous evidence [31,32], strain differences in
impulsivity emerged in that BL6 mice were more impulsive than
the HYB groups. The fact that basal motor impulsivity was distinct
in the two wildtype strains emphasizes the importance of
examining knockout mice on both background. Strain conferred
a performance advantage in all groups, with the exception of
Oprm1
2/2 mice, probably because these animals were already
responding at optimal levels. Indeed the performance of Oprm1
2/2
mice was so efficient that they made, on average, fewer than 5 pre-
CS responses during the 10
th training session. Compared to other
studies using the same task [15,33], our animals performed
exceptionally well with efficiency ratios of wild-type animals
Figure 2. Oprm1
2/2 mice perform better in the signaled nose poke task. Performance on Phase 4 of the signaled nose poke task for mu-
opioid receptor knockout mice and their wild-type controls on a HYB (A–D) and BL6 (E–H) backgrounds. A and E: Efficiency ratios (rewards/nose
pokes) increased across sessions with Oprm1
2/2 mice on both genetic backgrounds performing significantly better than wild-type controls. Mice
lacking the Oprm1 gene exhibited lower levels of responding throughout Phase 4 testing; this phenotypic difference was most apparent during the
pre-CS period (Fig. 2B and 2F), when animals must learn to inhibit responding in order to maximize the number of rewards earned. C and G:
Responses on the rewarded side during the 20-s inter-trial interval (ITI) decreased across sessions with lower overall responses in the Oprm1
2/2
groups and in the HYB strain. D and H: Conditioned responding (rewards/signals) increased across sessions with no genotype or background
differences. Oprm1
+/+ HYB, n=11; Oprm1
+/+ BL6, n=12; Oprm1
2/2 HYB, n=10; Oprm1
2/2 BL6, n=11.
doi:10.1371/journal.pone.0004410.g002
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differences, we used a visual rather than an auditory cue and liquid
rather than pellet sucrose reward. Either or all of these factors may
have increased the performance of wild-type mice and make it
even more surprising that we observed such a dramatic
enhancement in mice lacking the Oprm1 gene.
We also provide compelling evidence that Oprm
2/2 mice are
insensitive to the acute effects of ethanol in a signaled nose poke
task. This fits with evidence that mice lacking the Oprm1 gene show
reduced responses to ethanol in other behavioural tests [34] which
may be mediated by the reduction in ethanol-stimulated DA
release in the ventral striatum in Oprm1
2/2 mice [35]. We also
found that strain differences, which were apparent during
impulsivity testing, disappeared under the influence of ethanol.
This probably reflects increased experience with the task rather
than a drug-induced dampening of strain differences because BL6
and HYB wild-type mice showed the same level of performance
following vehicle injections. Thus, although strain may influence
impulsivity measures, the effect is not nearly as robust as the
Oprm1
2/2 and Oprm1
+/+ difference that was apparent in both
drugged and drug-free tests.
Higher activity under the influence of ethanol probably
accounts for the increased responses during both pre-CS and
ITI periods, producing lower efficiency ratios in both wild-type
and Oprd1
2/2 mice. The reduction in conditioned responses could
reflect a cognitive deficit that is manifested as an inability to detect
and/or respond to the visual stimulus. Even if this is true, mice
were not completely disoriented because responses on the non-
reinforced side did not change with ethanol administration (mean
responses per session ,10 for all groups). In light of these dramatic
effects of ethanol in wild-type and Oprd
2/2 mice, the most striking
finding is that the drug was completely ineffective in altering the
behavior of mice lacking the Oprm
2/2 gene.
Mechanisms by which mu- and delta-opioid receptors
regulate motor impulsivity remain to be elucidated: there are
several potential neural substrates for opioid-controlled disinhi-
bition. The decreased impulsivity we observed in Oprm1
2/2
mice could be mediated through an interaction with the
subthalamic nucleus (STN), dopamine (DA) D2 receptors in
the ventral striatum (VS), and/or excitatory projections from the
prefrontal cortex (PFC) to the striatum. Lesions of either the
PFC [36] or STN [37] increase impulsivity suggesting that
deletion of the Oprm1 gene may increase activity in either
structure. With regards to the STN, this hypothesis is plausible
as activation of mu-opioid receptors inhibits excitatory inputs to
the STN [38]: the absence of mu-opioid receptors would be
associated with increased excitation of STN neurons. The
possibility that mice lacking mu-opioid receptors exhibit
increased activity in PFC-striatal circuits is less convincing
because activation of mu-opioid receptors in the PFC inhibits
GABA interneurons that synapse on PFC projections [39].
Removal of opioid-induced inhibition of GABA neurons would
decrease activity in PFC projections. On the other hand, a
small population of mu-opioid receptors is located on PFC
Table 2. Nosepoke responses on the signaled nose task.
Group Phase 1 Phase 2 Phase 3 Phase 4
SNP non-RF Total non-RF Total non-RF total non-RF total
Oprm1
+/+ HYB 19.09 (3.08) 67.27 (7.73) 11.55 (2.48) 144.45 (15.32) 5.72 (1.67) 181.36 (10.23) 3.20 (0.89) 143.10 (10.79)
Oprm1
2/2 HYB 21.75 (3.77) 76.40 (9.49) 13.16 (3.03) 136.10 (16.89) 9.25 (2.48) 198.20 (13.91) 5.49 (1.75) 127.80 (11.87)
Oprm1
+/+ BL6 25.50 (5.80) 57.52 (8.04) 16.93 (3.65) 115.17 (12.5) 10.16 (2.72) 188.75 (19.99) 6.78 (2.12) 183.91 (20.44)
Oprm1
2/2 BL6 22.10 (4.29) 51.50 (8.49) 17.61 (4.74) 116.70 (15.42) 8.70 (2.50) 166.80 (15.63) 4.45 (1.77) 146.10 (11.61)
Oprd1
+/+ HYB 16.77 (2.63) 56.33 (8.70) 12.88 (2.24) 100.67 (11.23) 7.44 (2.02) 150.44 (18.74) 4.00 (1.36) 151.33 (18.75)
Oprd1
2/2 HYB 20.75 (3.98) 69.00 (8.75) 15.00 (2.0) 87.13 (9.17) 13.00 (3.68) 155.25 (20.46) 6.25 (1.36) 149.50 (15.36)
Oprd1
+/+ BL6 25.50 (5.80) 57.52 (8.04) 16.93 (3.65) 115.17 (12.5) 10.16 (2.72) 188.75 (19.99) 6.78 (2.12) 183.91 (20.44)
Oprd1
2/2 BL6 18.20 (3.78) 86.90 (9.69) 19.70 (3.33) 135.7 (15.36) 19.90 (3.81) 158.00 (13.81) 9.00 (2.17) 182.80 (10.51)
The two columns under each phase display mean nose pokes (SEM) in the non-reinforced (non-RF) hole (left column) and total nose pokes (right column) during the
final session of Phases 1–3 (i.e., the day the animals met criterion) and the first session of Phase 4. Note that the number of sessions in Phases 1–3 varied for each animal,
depending on the days to reach criterion. There were no significance differences between knockout and wild-type animals on any measure.
Oprm1
+/+ HYB, n=11; Oprm1
2/2 HYB, n=10;Oprm1
+/+ BL6, n=12;
Oprm1
2/2 BL6, n=11
Oprd1
+/+ HYB, n=9; Oprd1
2/2 HYB, n=8; Oprd1
+/+ BL6, n=12;
Oprd1
2/2 BL6, n=10
doi:10.1371/journal.pone.0004410.t002
Figure 3. Oprd1
2/2 mice are impaired in the signaled nose poke task. Performance on Phase 4 of the signaled nose poke task for delta-
opioid receptor knockout mice and their wild-type controls on a HYB (A–D) or BL6 (E–H) background. A: Efficiency ratios (rewards/nosepokes)
increased across 10 sessions indicating that all groups were capable of learning the task. Both HYB and BL6 Oprd1
2/2 mice exhibited lower efficiency
ratios (i.e., more impulsivity) than their wild-type controls. The significant background effect reflected the fact that both knockout and wild-type BL6
mice were more impulsive than mice on a HYB background. B and F: Responses during the pre-CS period also declined across sessions although the
effect was not as pronounced in Oprd1
2/2 mice. Again, responses of HYB mice were increased compared to mice on a BL6 background. C and G:
Responses during the 20-s inter-trial interval (ITI) decreased across sessions and the rate of decline was consistent across groups. Nonetheless, HYB
mice responded at higher rates than BL6 mice of both genotypes throughout the sessions. D and H: Conditioned responding (rewards/signals)
increased across sessions, but there were no genotype or background differences on this measure and no statistically significant interactions. Oprd1
+/
+ HYB, n=9; Oprd1
+/+ BL6, n=12; Oprd1
2/2 HYB, n=8; Oprd1
2/2 BL6, n=10.
doi:10.1371/journal.pone.0004410.g003
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increase PFC activity by directly removing this inhibitory input.
Finally, decreased availability of DA D2-like receptors in the VS
is associated with high levels of trait impulsivity [41] suggesting
that knockout mice may exhibit increased signaling in DA D2
pathways. This idea fits with evidence that mice lacking the
Oprm1 gene show increased DA D2 receptor binding in the
striatum and increased activity levels when the receptor is
stimulated [42]. Much less is known about delta receptor
function in these brain areas, or about D2/delta receptor
interactions. In addition, the effect of selective opioid receptor
ligands in the STN, PFC or VS on impulsive responding has
not been tested directly. The deletion of the Oprm1 and Oprd1
genes may, together, alter inhibitory mechanisms through one
or more of these neural systems.
An important remaining question is whether deletion of the
Oprm1 or Oprd1 genes affect other measures of impulsivity, such as
delay-discounting or reflection impulsivity. The latter is particu-
Figure 4. Oprm1
2/2 mice are not affected by ethanol in the signaled nose poke task. A: Efficiency ratios (rewards/nosepokes) decreased
with increasing doses of ethanol, but only in wild-type mice. B: The same effect was observed during the pre-CS period. There were no significant
strain differences on any behavioral measure during ethanol testing, nor were there any strain-dose interactions. C: Ethanol increased nose pokes that
occurred during the inter-trial interval (ITI) in wild-type but not knockout animals. D: Ethanol also altered conditioned responses in Oprm1
+/+ , but not
Oprm1
2/2 mice. The highest dose of ethanol (1.75 g/kg) produced the greatest effect on conditioned responses in wild-type mice. Oprm1
+/+ HYB,
n=11; Oprm1
+/+ BL6, n=12; Oprm1
2/2 HYB, n=10; Oprm1
2/2 BL6, n=11.
doi:10.1371/journal.pone.0004410.g004
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substance dependence that does not recover with prolonged
abstinence and is associated with multiple drugs of abuse [43]. The
importance of impulsivity in addiction is emphasized further by a
relationship between level of abuse and treatment retention [44].
Finally, beyond addiction, the role of the Oprm1 and Oprd1 genes in
impulsivity has implications for understanding and treating
attention deficit hyperactivity disorder, eating disorders, gambling
and other disorders of impulse control.
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Figure 5. Oprd1
2/2 and Oprd1
+/+ mice are impaired by ethanol in the signaled nose poke task. A: Ethanol produced a dose-dependent
decrease in efficiency ratios (rewards/nosepokes) in all groups of animals, with knockout mice displaying lower efficiency ratios throughout testing. B:
Ethanol increased nose pokes that occurred during the 1–8 s pre-CS period and during the inter-trial interval (ITI) (C). Both wild-type and knockout
mice on a BL6 background exhibited higher rates of responding than HYB mice during the ITI but this effect did not interact with dose or with group.
D: Ethanol altered conditioned responses in both Oprd1
+/+ and Oprd1
2/2 mice, although only the highest dose (1.75 g/kg) produced an effect.
Oprd1
+/+ HYB, n=9; Oprd1
+/+ BL6, n=12; Oprd1
2/2 HYB, n=8; Oprd1
2/2 BL6, n=10.
doi:10.1371/journal.pone.0004410.g005
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